Resource
Cerliponase alfa ▼ is not registered in all countries, and where it is registered the content of its indication along with other content may vary.
Please refer to your local prescribing information before prescribing cerliponase alfa.
▼ This medicinal product is subject to additional monitoring, special reporting is required in relation to adverse reactions. Email us at medinfo@bmrn.com for further details.
Explore foundational and emerging topics in genetics and genomics. This sections offers ahcance to refrsh core knoledge while staying current on the latest innovations influencing CLN2 diagnosis and research.
Resource